Navigation Links
Faulty Dosing Device Prompts Recall of Infants' Tylenol
Date:2/17/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 17 (HealthDay News) -- A potentially faulty dosing system on bottles of Infants' Tylenol has prompted McNeil Consumer Healthcare, a division of Johnson & Johnson, to recall all of the product.

The voluntary recall comes in response to some consumer complaints about the product's so-called SimpleMeasure dosing system, which dispenses measured doses of the medication.

The system includes a dosing syringe that an adult inserts into the cover at the top of the bottle. It's supposed to limit the amount of Tylenol that can be delivered in a single dose, according to the company.

In some cases, inserting the syringe pushed this "flow restrictor" into the bottle.

"Parents can continue to use the product as long as the flow restrictor is in place," Johnson & Johnson spokeswoman Bonnie Jacobs said. "If the flow restrictor does push into the bottle, then they should stop using it and contact us."

According to the company, there have been no adverse events reported due to the problem, "and the risk of a serious adverse medical event is remote."

Jacobs said she didn't know when Infants' Tylenol would be available again. "We're conducting a full review to determine why it's not performing as expected. We are looking at different options," she said.

The recall affects only Infants' Tylenol. Children's Tylenol, which is for use by children 2 years of age and older, remains on the market, Jacobs said.

More information

For more information, visit Johnson & Johnson.

SOURCE: Bonnie Jacobs, spokeswoman, Johnson & Johnson


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Journal Retracts Faulty Chronic Fatigue Study
2. Autism Tests for Preemies May Be Faulty, Study Suggests
3. Faulty off-switch stops children with ADHD from concentrating
4. Drug Targets Faulty Process That Drives Cystic Fibrosis
5. Web Site for Hospital Comparisons Is Faulty: Study
6. Faulty gene stops cell antennae from transmitting
7. Variation in make-up of generic epilepsy drugs can lead to dosing problems
8. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
9. Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine
10. Confusion Over Drug Dosing Common for Seniors
11. Cough Syrup Might Help With Dosing of Breast Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Faulty Dosing Device Prompts Recall of Infants' Tylenol
(Date:9/22/2017)... ... September 22, 2017 , ... TopConsumerReviews.com ... by Native Remedies that helps promote pancreatic health and regulate blood sugar ... some prescription-based approaches can have negative side effects, and with the changes in ...
(Date:9/22/2017)... , ... September 22, 2017 , ... “Letters From Home”: ... people, even the lost, have value to God. “Letters From Home” is the creation ... a member of the President’s Cabinet of Jerry Savelle Ministries International, who has traveled ...
(Date:9/21/2017)... ... September 21, 2017 , ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery ... is pleased to announce that Plastic Surgeon Kiranjeet Gill has been awarded as one ... is an annual award that was started in 2003 to salute young achievers in ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for Children® ... the election of Yie-Hsin Hung to the Board of Directors. , “The New ... Directors. Ms. Hung is an invaluable addition to our team,” said Vincent Strully, Jr., ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... focused on the development of oral drug delivery systems, ... with the U.S. Food and Drug Administration (FDA) regarding ... At the meeting, the FDA ... of ORMD-0801, would be a Biologics License Application (BLA).  ...
(Date:9/1/2017)... WHIPPANY, N.J. , Sept. 1, 2017  Bayer will ... at the European Society for Medical Oncology (ESMO) 2017 Congress, ... studies presented will include new preclinical and clinical data on ... from two earlier pipeline projects. ... of the best minds in cancer research at ESMO," said ...
(Date:8/29/2017)... RANDOLPH, N.J. , Aug. 29, 2017 ... inventory management, security, and regulatory compliance for veterinary practices ... today announced a new partnership that makes TITAN,s expertise ... legal compliance available to Cubex,s clients nationally. ... healthcare provider buying and handling controlled substances is at ...
Breaking Medicine Technology: